Non-Executive Directors

Johan Goossens, Chairman of the Board

Johan Goossens co-founded the Company in 2000 having gained over 20 years’ experience in private and investment banking, starting with KBC in 1979 and holding positions at a number of other institutions, including Nedee & Co, Defever and BNP-Naegelmackers. He left BNP-Naegelmackers in 1994 to focus on ‘Beurstips’, a weekly investment magazine published in Belgium, which he founded in 1992. This publication grew to be one of the most successful Belgian investor magazines and was sold by J. Goossens in 2005. J. Goossens holds a Bachelor of Economics degree from the High School of Ghent as well as a postgraduate qualification in marketing.


Walter van Pottelberge
Walter van Pottelberge joined the Company’s Board as a Non-Executive Director in 2007. W. Van Pottelberge was Chief Executive Officer of ING Insurance Belgium-Luxembourg for eight years up until 2001. W. Van Pottelberge was also president of the executive committee of Mercator Bank NV between 2003 and 2005. He served on the advisory board of Goffin bank since 2005 where he was also Chairman of the Audit Committee. W. Van Pottelberge serves on various other company boards and organizations including UBCA N.V., DELA Re, VOKA, Argenta (where he serves as a member of the Audit Committee), Inventive Designers, Private Insurer (president of the Audit Committee), Record Credit Services (president of the Audit Committee), Gudrun Group, the University of Antwerp and Vlerik Leuven Management School. W. Van Pottelberge holds a university degree in physics and actuarial science from Leuven University.

Ronald Lorijn

Dr. Ronald Lorijn (MD, PhD, MBA) joined the company as a Non-Executive Director in May 2010. Previously, Dr. Lorijn was Chief Executive of AMT NV (Amsterdam), having developed AMT from a small, one-product operation into a leading therapy company listed on the NYSE Euronext. He retired from AMT in February 2009. Prior to AMT, Dr. Lorijn was a member of Amgen, a leading human therapeutics company, where he was part of Amgen Europe’s executive management team and responsible for its Clinical Operations, Business Development & Governmental Affairs. Before joining Amgen he was Chief Medical Officer and Senior Director of Clinical Operations & Medical Affairs, Europe at Centocor after having been employed by the pharmaceutical division of AKZO (Organon), as its head of worldwide Medical Services and Product Surveillance. Dr. Lorijn graduated from the Radboud University Nijmegen, completed a Ph.D. and was a certified obstetrician/gynaecologist before joining the biotech industry.